IBOLEX
200MG TBL FLM 50 I
| SÚKL code | 0239286 |
|---|---|
| Name of the product | IBOLEX |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | IBOLEX |
| Supplement | 200MG TBL FLM 50 I |
| Strenght | 200MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 50 I |
| Route | Oral use |
| Language of the pack | Czech |
| Wrap type | Blister |
| Legal status | OTC medicinal products |
| Active substance | DEXIBUPROFEN (DEXIBUPROFENUM) |
| ATC group | M01AE14 |
| ATC group name | DEXIBUPROFEN |
Marketing authorisation information
| Registration Number | 29/ 199/19-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 12. 2021 |
| MA Holder | sanofi-aventis, s.r.o., Praha |
| MA Holder country | ČESKÁ REPUBLIKA |
| Actual MA holder | Opella Healthcare Czech s.r.o., Praha |
| Actual MA holder country | ČESKÁ REPUBLIKA |
cz